Research progress of histone lactylation in immunomodulation after traumatic brain injury
10.3760/cma.j.cn501098-20221208-00788
- VernacularTitle:组蛋白乳酸化在创伤性脑损伤免疫调控中作用的研究进展
- Author:
Quanxing WU
1
;
Axiang ZHOU
;
Zaiyun LONG
;
Yongtang WANG
;
Ying YU
;
Ce YANG
Author Information
1. 陆军军医大学大坪医院野战外科研究部特殊环境战伤防治研究室，创伤、烧伤与复合伤国家重点实验室，重庆 400042
- Keywords:
Brain injuries, traumatic;
Glycolysis;
Metabolism;
Histone lysine lactylation
- From:
Chinese Journal of Trauma
2023;39(7):659-664
- CountryChina
- Language:Chinese
-
Abstract:
Traumatic brain injury (TBI) is a major reason for temporary or permanent dyskinesia and cognitive impairment of the organism. Generally, TBI induces subsequent neuroinflammation to assist cell debris removal and tissue repair and regeneration after injury. However, overactivation or long-term activation of immune cells will exacerbate nerve damage or death, cause cognitive dysfunction, and ultimately lead to neurodegenerative diseases. Therefore, secondary damage caused by persistent inflammation is a key component of TBI pathological process. As the main metabolite of anaerobic glycolysis, lactate is increased after TBI and participates in brain inflammation as an important immune regulatory molecule rather than a metabolic waste. Importantly, histone lysine lactylation as a novel type of histone post-translational modifications (HPTM) derived from lactate allows lactate to participate in the regulation of complex immunopathophysiological processes of the central nervous system after TBI. Further study on the process of histone lactylation and its immune regulation mechanism during TBI may provide new insights for early intervention and improvement of TBI prognosis. Thus, the authors reviewed the role of histone lactylation in the immune regulation of TBI, so as to further elucidate the mechanism of TBI and the explore new warning and prevention measures from the perspective of HPTM.
